Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Dzwonczyk S

Collect these papers and discover other ones on Labmeeting. Learn more.

Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivity.

+ cite this

+ View Abstract

Rovnyak GC, Ahmed SZ, Ding CZ, Dzwonczyk S, Ferrara FN, Humphreys WG, Grover GJ, Santafianos D, Atwal KS, Baird AJ, McLaughlin LG, Normandin DE, Sleph PG, and Traeger SC

Journal of medicinal chemistry 40(1):24-34, 1997 Jan 3 - Who cited this? | PubMed ID: 9016325 | Fulltext

Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.

+ cite this

+ View Abstract

Grover GJ, Sleph PG, Dzwonczyk S, Malone HJ, and Behling RW

Journal of cardiovascular pharmacology 29(1):28-38, 1997 Jan - Who cited this? | PubMed ID: 9007667 | Fulltext

Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilide.

+ cite this

+ View Abstract

Grover GJ, D'Alonzo AJ, Dzwonczyk S, Parham CS, and Darbenzio RB

The American journal of physiology 271(3 Pt 2):H1207-14, 1996 Sep - Who cited this? | PubMed ID: 8853361 | Fulltext

Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A2 inhibition in ischemic rat hearts.

+ cite this

+ View Abstract

Sargent CA, Wilde MW, Dzwonczyk S, Tuttle JG, Murray HN, Atwal K, and Grover GJ

Cardiovascular research 31(2):270-7, 1996 Feb - Who cited this? | PubMed ID: 8730404 | Fulltext

Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.

+ cite this

+ View Abstract

D'Alonzo AJ, Grover GJ, Darbenzio RB, Sewter JC, Hess TA, Dzwonczyk S, and Sleph PG

Pharmacology 52(2):101-12, 1996 Feb - Who cited this? | PubMed ID: 8851631 | Fulltext

Cardioselective antiischemic ATP-sensitive potassium channel openers. 4. Structure-activity studies on benzopyranylcyanoguanidines: replacement of the benzopyran portion.

+ cite this

+ View Abstract

Atwal KS, Ferrara FN, Ding CZ, Grover GJ, Sleph PG, Dzwonczyk S, Baird AJ, and Normandin DE

Journal of medicinal chemistry 39(1):304-13, 1996 Jan 5 - Who cited this? | PubMed ID: 8568821 | Fulltext

Comparative cardioprotective effects of cromakalim and diltiazem in ischemic hypertrophied rat hearts.

+ cite this

+ View Abstract

Grover GJ, Dzwonczyk S, and Monticello TM

The American journal of physiology 270(1 Pt 2):H174-82, 1996 Jan - Who cited this? | PubMed ID: 8769749 | Fulltext

Cardioselective anti-ischemic ATP-sensitive potassium channel openers. 3. Structure-activity studies on benzopyranyl cyanoguanidines: modification of the cyanoguanidine portion.

+ cite this

+ View Abstract

Atwal KS, Grover GJ, Ahmed SZ, Sleph PG, Dzwonczyk S, Baird AJ, and Normandin DE

Journal of medicinal chemistry 38(17):3236-45, 1995 Aug 18 - Who cited this? | PubMed ID: 7650676 | Fulltext

Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,926 [correction of SQ 32,946].

+ cite this

+ View Abstract

Grover GJ, Dzwonczyk S, McMullen DM, Normandin DE, Parham CS, Sleph PG, and Moreland S

Journal of cardiovascular pharmacology 26(2):289-94, 1995 Aug - Who cited this? | PubMed ID: 7475054 | Fulltext

Cardioselective antiischemic ATP-sensitive potassium channel openers. 2. Structure-activity studies on benzopyranylcyanoguanidines: modification of the benzopyran ring.

+ cite this

+ View Abstract

Atwal KS, Grover GJ, Ferrara FN, Ahmed SZ, Sleph PG, Dzwonczyk S, and Normandin DE

Journal of medicinal chemistry 38(11):1966-73, 1995 May 26 - Who cited this? | PubMed ID: 7783128 | Fulltext

The KATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat hearts.

+ cite this

+ View Abstract

Grover GJ, Murray HN, Baird AJ, and Dzwonczyk S

European journal of pharmacology 277(2-3):271-4, 1995 Apr 24 - Who cited this? | PubMed ID: 7493619 | Fulltext

In vitro effects of capsaicin: antiarrhythmic and antiischemic activity.

+ cite this

+ View Abstract

D'Alonzo AJ, Grover GJ, Darbenzio RB, Hess TA, Sleph PG, Dzwonczyk S, Zhu JL, and Sewter JC

European journal of pharmacology 272(2-3):269-78, 1995 Jan 16 - Who cited this? | PubMed ID: 7713171 | Fulltext

Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart.

+ cite this

+ View Abstract

Weselcouch EO, Baird AJ, Sleph PG, Dzwonczyk S, Murray HN, and Grover GJ

Cardiovascular research 29(1):126-32, 1995 Jan - Who cited this? | PubMed ID: 7895230 | Fulltext

Pyruvate increases threshold for preconditioning in globally ischemic rat hearts.

+ cite this

+ View Abstract

Sargent CA, Dzwonczyk S, Sleph P, Wilde M, and Grover GJ

The American journal of physiology 267(4 Pt 2):H1403-9, 1994 Oct - Who cited this? | PubMed ID: 7943385 | Fulltext

The effect of alpha 2-adrenoceptor antagonists in isolated globally ischemic rat hearts.

+ cite this

+ View Abstract

Sargent CA, Dzwonczyk S, and Grover GJ

European journal of pharmacology 261(1-2):25-32, 1994 Aug 11 - Who cited this? | PubMed ID: 8001650 | Fulltext

The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.

+ cite this

+ View Abstract

Grover GJ, D'Alonzo AJ, Sleph PG, Dzwonczyk S, Hess TA, and Darbenzio RB

The Journal of pharmacology and experimental therapeutics 269(2):536-40, 1994 May - Who cited this? | PubMed ID: 8182522 | Fulltext

Cardioselective anti-ischemic ATP-sensitive potassium channel openers.

+ cite this

Atwal KS, Grover GJ, Ahmed SZ, Ferrara FN, Harper TW, Kim KS, Sleph PG, Dzwonczyk S, Russell AD, and Moreland S

Journal of medicinal chemistry 36(24):3971-4, 1993 Nov 26 - Who cited this? | PubMed ID: 8254626 | Fulltext

Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.

+ cite this

+ View Abstract

Grover GJ, Sleph PG, Dzwonczyk S, and McCullough JR

The Journal of pharmacology and experimental therapeutics 267(1):102-7, 1993 Oct - Who cited this? | PubMed ID: 8229736 | Fulltext

Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075.

+ cite this

+ View Abstract

Sargent CA, Sleph PG, Dzwonczyk S, Normandin D, Antonaccio MJ, and Grover GJ

Journal of cardiovascular pharmacology 22(4):564-70, 1993 Oct - Who cited this? | PubMed ID: 7505358 | Fulltext

Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat hearts.

+ cite this

+ View Abstract

Grover GJ, Sargent CA, Dzwonczyk S, Normandin DE, and Antonaccio MJ

Journal of cardiovascular pharmacology 22(4):664-72, 1993 Oct - Who cited this? | PubMed ID: 7505371 | Fulltext

The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion.

+ cite this

+ View Abstract

Grover GJ, Dzwonczyk S, and Parham CS

Cardiovascular research 27(9):1613-8, 1993 Sep - Who cited this? | PubMed ID: 8287438 | Fulltext

The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.

+ cite this

+ View Abstract

Grover GJ, Dzwonczyk S, Sleph PG, and Sargent CA

The Journal of pharmacology and experimental therapeutics 265(2):559-64, 1993 May - Who cited this? | PubMed ID: 8496806 | Fulltext

Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.

+ cite this

+ View Abstract

Sargent CA, Sleph PG, Dzwonczyk S, Smith MA, Normandin D, Antonaccio MJ, and Grover GJ

The Journal of pharmacology and experimental therapeutics 265(2):609-18, 1993 May - Who cited this? | PubMed ID: 8496812 | Fulltext

Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors.

+ cite this

+ View Abstract

Grover GJ, Sleph PG, and Dzwonczyk S

Circulation 86(4):1310-6, 1992 Oct - Who cited this? | PubMed ID: 1394937 | Fulltext

Effect of calmodulin and protein kinase C inhibitors on globally ischemic rat hearts.

+ cite this

+ View Abstract

Sargent CA, Sleph PG, Dzwonczyk S, Smith MA, and Grover GJ

Journal of cardiovascular pharmacology 20(2):251-60, 1992 Aug - Who cited this? | PubMed ID: 1381016 | Fulltext

Effect of the potassium channel opener EMD 56431 on globally ischemic rat hearts.

+ cite this

+ View Abstract

Sargent CA, Dzwonczyk S, and Grover GJ

Pharmacology 45(5):260-8, 1992 - Who cited this? | PubMed ID: 1465473 | Fulltext

Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents.

+ cite this

+ View Abstract

Sargent CA, Smith MA, Dzwonczyk S, Sleph PG, and Grover GJ

The Journal of pharmacology and experimental therapeutics 259(1):97-103, 1991 Oct - Who cited this? | PubMed ID: 1920138 | Fulltext

Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate.

+ cite this

+ View Abstract

McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, and Grover GJ

Circulation research 69(4):949-58, 1991 Oct - Who cited this? | PubMed ID: 1934346 | Fulltext

Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.

+ cite this

+ View Abstract

Grover GJ, Sleph PG, Dzwonczyk S, Wang P, Fung W, Tobias D, and Cushman DW

The Journal of pharmacology and experimental therapeutics 257(3):919-29, 1991 Jun - Who cited this? | PubMed ID: 1646329 | Fulltext

Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.

+ cite this

+ View Abstract

Grover GJ, Newburger J, Sleph PG, Dzwonczyk S, Taylor SC, Ahmed SZ, and Atwal KS

The Journal of pharmacology and experimental therapeutics 257(1):156-62, 1991 Apr - Who cited this? | PubMed ID: 2019983 | Fulltext

Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs.

+ cite this

+ View Abstract

Grover GJ, Sleph PG, and Dzwonczyk S

Journal of cardiovascular pharmacology 16(6):853-64, 1990 Dec - Who cited this? | PubMed ID: 1704976 | Fulltext

Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891.

+ cite this

+ View Abstract

Grover GJ, Dzwonczyk S, and Sleph PG

European journal of pharmacology 191(1):11-8, 1990 Nov 20 - Who cited this? | PubMed ID: 2128745 | Fulltext

Ruthenium red improves postischemic contractile function in isolated rat hearts.

+ cite this

+ View Abstract

Grover GJ, Dzwonczyk S, and Sleph PG

Journal of cardiovascular pharmacology 16(5):783-9, 1990 Nov - Who cited this? | PubMed ID: 1703601 | Fulltext

The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs.

+ cite this

+ View Abstract

Grover GJ, Dzwonczyk S, Parham CS, and Sleph PG

Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 4(2):465-74, 1990 Apr - Who cited this? | PubMed ID: 2285630 | Fulltext

Comparative anti-ischemic effects of dihydropyridine calcium antagonists in isolated perfused rat hearts: relationship of cardiodepression and cardioprotection.

+ cite this

+ View Abstract

Grover GJ, Dzwonczyk S, and Sleph PG

Pharmacology 40(3):137-49, 1990 - Who cited this? | PubMed ID: 2333320 | Fulltext

Search Google Scholar for Dzwonczyk S

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!